Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Bullboard Posts
Comment by old_dogon Nov 05, 2020 6:36pm
195 Views
Post# 31848835

RE:RE:RE:Questions for Old Dog

RE:RE:RE:Questions for Old Dog I think what is different here is you have a CEO that has a proven record of getting things done. Don't get me wrong at this stage it's a wee bit of a cluster box....but bringing something to market is never a piece of cake...if it was everyone would be doing it. What I see different here is that the CEO does have that proven track record and that this is the type of Tech that will come into its own sooner than later. No one foresaw the Covid 19 issue or the way it would radically affect the heart. Considering the amount of cases in the US alone They racked up 100K new cases today...and are just 100K short of 10 million cases. If just 2% of those people require monitoring for a period of time your talking 200,000 repeat visits to the doctor to monitor their covid 19 heart damage.

I see many things here....but it all comes down to acceptance of the product which at this stage of the game is not even an issue due to the constant modifications/enhancements. I see multiple reasons/medical impairment reasons.....old age...chemo...covid...that will lead to a heavier usage requirement than even the CEO is forcasting. I see a constant revenue stream from usage that will increase.....I mean everywhere I look for weakness I can't find it...yes the company is walking a tight line right now as far as cash runway...but that should peel off pretty soon.


Once the company gets more units out there it should have brokers looking to get into it.



Back to HUGE....there were two things that always made me wonder ...the voting shares...what 6 people could vote????......second was the "Australian Model"....When the ceo said that I had schivers going through me...Austalian Model...what the Dell is that I thought...what did they have 1.3 billion shares????...


old_dog


Bullboard Posts